![JCM | Free Full-Text | Asymptomatic Left Ventricular Hypertrophy Is a Potent Risk Factor for the Development of HFpEF but Not HFrEF: Results of a Retrospective Cohort Study JCM | Free Full-Text | Asymptomatic Left Ventricular Hypertrophy Is a Potent Risk Factor for the Development of HFpEF but Not HFrEF: Results of a Retrospective Cohort Study](https://www.mdpi.com/jcm/jcm-11-03885/article_deploy/html/images/jcm-11-03885-g001.png)
JCM | Free Full-Text | Asymptomatic Left Ventricular Hypertrophy Is a Potent Risk Factor for the Development of HFpEF but Not HFrEF: Results of a Retrospective Cohort Study
![Controversies in Diagnostic Imaging of Patients With Suspected Stable and Acute Chest Pain Syndromes | JACC: Cardiovascular Imaging Controversies in Diagnostic Imaging of Patients With Suspected Stable and Acute Chest Pain Syndromes | JACC: Cardiovascular Imaging](https://www.jacc.org/cms/asset/889be5fb-0cb1-4ac1-bdf0-d1f43f036b0c/fx1.jpg)
Controversies in Diagnostic Imaging of Patients With Suspected Stable and Acute Chest Pain Syndromes | JACC: Cardiovascular Imaging
![Randomized Comparison of Clinical Effectiveness of Pharmacologic SPECT and PET MPI in Symptomatic CAD Patients | JACC: Cardiovascular Imaging Randomized Comparison of Clinical Effectiveness of Pharmacologic SPECT and PET MPI in Symptomatic CAD Patients | JACC: Cardiovascular Imaging](https://www.jacc.org/cms/asset/02879f32-752b-4e8e-aa62-212fba72f6be/fx1.jpg)
Randomized Comparison of Clinical Effectiveness of Pharmacologic SPECT and PET MPI in Symptomatic CAD Patients | JACC: Cardiovascular Imaging
![c-Mpl-del, a c-Mpl alternative splicing isoform, promotes AMKL progression and chemoresistance | Cell Death & Disease c-Mpl-del, a c-Mpl alternative splicing isoform, promotes AMKL progression and chemoresistance | Cell Death & Disease](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41419-022-05315-5/MediaObjects/41419_2022_5315_Fig1_HTML.png)